Of note, the relative risk (RR) for non-fatal and fatal stroke in patients who received these agents vs conventional treatment was 1.07 (95%CI: 0.68-1.69) and 1.17 (95%CI: 0.54-2.54), respectively, indicating a negative trend for the effects of sulfonylureas[ 9 ].
1
—
—